Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells

Novel 1,3,4-oxadiazole induces anticancer activity by targeting NF-κB in hepatocellular carcinoma cells

Aberrant activation of NF-κB is linked with the progression of human malignancies including hepatocellular carcinoma (HCC), and blockade of NF-κB signaling could be a potential target in the treatment of several cancers. Therefore, designing of novel small molecule inhibitors that target NF-κB ac...

Full description

Bibliographic Details
Main Authors: Mohan, C., Anilkumar, N., Rangappa, S., Shanmugam, M., Mishra, S., Chinnathambi, A., Alharbi, S., Bhattacharjee, A., Sethi, G., Kumar, Alan Prem, Basappa, Rangappa, K.
Format: Journal Article
Published: Frontiers Research Foundation 2018
Online Access:http://hdl.handle.net/20.500.11937/67557

Internet

http://hdl.handle.net/20.500.11937/67557

Similar Items